Surgical Management of High-Risk Breast Lesions

Surgical Clinics of North America

Volumn 93, Issue 2, 2013, Pages 329-340

  Degnim, Amy C ^a   King, Tari A ^b  

^a MAYO CLINIC   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Atypical hyperplasia; Breast cancer risk; High risk lesion; Lobular carcinoma in situ; Papillary lesions; Percutaneous breast biopsy; Radial scar

Indexed keywords

RALOXIFENE; TAMOXIFEN;

ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL LOBULAR HYPERPLASIA; BREAST BIOPSY; BREAST CANCER; BREAST FLAT EPITHELIAL ATYPIA; BREAST LESION; BREAST PAPILLARY LESION; BREAST PAPILLOMA; BREAST SURGERY; CANCER RISK; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INTRADUCTAL PAPILLARY CARCINOMA; INVASIVE PAPILLARY CARCINOMA; LOBULAR CARCINOMA IN SITU; MAMMOGRAPHY; MASTECTOMY; MORBIDITY; PATIENT COUNSELING; PATIENT SAFETY; PERCUTANEOUS BIOPSY; PRIORITY JOURNAL; RADIAL SCAR; REVIEW; RISK REDUCTION;

BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CICATRIX; FEMALE; HUMANS; HYPERPLASIA; MASTECTOMY; PAPILLOMA, INTRADUCTAL; PRECANCEROUS CONDITIONS; RISK;

EID: 84875296706     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.12.005     Document Type: Review

References (68)

1. Haagensen C.D., Lane N., Lattes R., et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978, 42(2):737-769.
2. Dupont W.D., Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312(3):146-151.
3. Burbank F. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: improved accuracy with directional, vacuum-assisted biopsy. Radiology 1997, 202(3):843-847.
4. Corben A.D., Edelweiss M., Brogi E. Challenges in the interpretation of breast core biopsies. Breast J 2010, 16(Suppl 1):S5-S9.
5. Jackman R.J., Birdwell R.L., Ikeda D.M. Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision?. Radiology 2002, 224(2):548-554.
6. Pandelidis S., Heiland D., Jones D., et al. Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions. Ann Surg Oncol 2003, 10(1):43-47.
7. Winchester D.J., Bernstein J.R., Jeske J.M., et al. Upstaging of atypical ductal hyperplasia after vacuum-assisted 11-gauge stereotactic core needle biopsy. Arch Surg 2003, 138(6):619-622. [discussion: 622-3].
8. Green S., Khalkhali I., Azizollahi E., et al. Excisional biopsy of borderline lesions after large bore vacuum-assisted core needle biopsy- is it necessary?. Am Surg 2011, 77(10):1358-1360.
9. Houssami N., Ciatto S., Ellis I., et al. Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer 2007, 109(3):487-495.
10. Sohn V., Arthurs Z., Herbert G., et al. Atypical ductal hyperplasia: improved accuracy with the 11-gauge vacuum-assisted versus the 14-gauge core biopsy needle. Ann Surg Oncol 2007, 14(9):2497-2501.
11. American College of Radiology. Practice guidelines for performance of ultrasound-guided percutaneous breast interventional procedures. 2009. Available at:. Accessed January 24, 2013. http://www.acr.org%7E/media/ACR/Documents/PGTS/guidelines/US_Guided_Breast.pdf.
12. American College of Radiology. Practice guidelines for the performance of stereotactically guided breast interventional procedures. Rev. 2009. Available at:. Accessed June 25, 2011. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/stereotactically_guided_breast.aspx.
13. Johnson N.B., Collins L.C. Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol 2009, 16(4):183-195.
14. Landercasper J., Linebarger J.H. Contemporary breast imaging and concordance assessment: a surgical perspective. Surg Clin North Am 2011, 91(1):33-58.
15. Masood S., Rosa M. Borderline breast lesions: diagnostic challenges and clinical implications. Adv Anat Pathol 2011, 18(3):190-198.
16. The American Society of Breast Surgeons. Position statement on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. 2011. Available at:. Accessed September 30, 2010. http://https://www.breastsurgeons.org/statements/PDF_Statements/Concordance_Assessment.pdf.
17. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer 1985, 55(11):2698-2708.
18. Burak W.E., Owens K.E., Tighe M.B., et al. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Arch Surg 2000, 135(6):700-703.
19. Deshaies I., Provencher L., Jacob S., et al. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Breast 2011, 20(1):50-55.
20. Rizzo M., Lund M.J., Oprea G., et al. Surgical follow-up and clinical presentation of 142 breast papillary lesions diagnosed by ultrasound-guided core-needle biopsy. Ann Surg Oncol 2008, 15(4):1040-1047.
21. Gendler L.S., Feldman S.M., Balassanian R., et al. Association of breast cancer with papillary lesions identified at percutaneous image-guided breast biopsy. Am J Surg 2004, 188(4):365-370.
22. Valdes E.K., Tartter P.I., Genelus-Dominique E., et al. Significance of papillary lesions at percutaneous breast biopsy. Ann Surg Oncol 2006, 13(4):480-482.
23. Renshaw A.A., Derhagopian R.P., Tizol-Blanco D.M., et al. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision. Am J Clin Pathol 2004, 122(2):217-221.
24. Sohn V., Porta R., Brown T. Flat epithelial atypia of the breast on core needle biopsy: an indication for surgical excision. Mil Med 2011, 176(11):1347-1350.
25. Lavoue V., Roger C.M., Poilblanc M., et al. Pure flat epithelial atypia (DIN 1a) on core needle biopsy: study of 60 biopsies with follow-up surgical excision. Breast Cancer Res Treat 2011, 125(1):121-126.
26. Chivukula M., Bhargava R., Tseng G., et al. Clinicopathologic implications of " flat epithelial atypia" in core needle biopsy specimens of the breast. Am J Clin Pathol 2009, 131(6):802-808.
27. Subhawong A.P., Subhawong T.K., Khouri N., et al. Incidental minimal atypical lobular hyperplasia on core needle biopsy: correlation with findings on follow-up excision. Am J Surg Pathol 2010, 34(6):822-828.
28. Shah-Khan M.G., Geiger X.J., Reynolds C., et al. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol 2012, 19:3131-3138.
29. Renshaw A.A., Derhagopian R.P., Martinez P., et al. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Am J Clin Pathol 2006, 126(2):310-313.
30. Karabakhtsian R.G., Johnson R., Sumkin J., et al. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol 2007, 31(5):717-723.
31. Brem R.F., Lechner M.C., Jackman R.J., et al. Lobular neoplasia at percutaneous breast biopsy: variables associated with carcinoma at surgical excision. AJR Am J Roentgenol 2008, 190(3):637-641.
32. Rendi M.H., Dintzis S.M., Lehman C.D., et al. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy. Ann Surg Oncol 2012, 19(3):914-921.
33. Murray M.P., Luedtke C., Liberman L., et al. Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: Outcomes of prospective excision. Cancer 2012, [Epub ahead of print].
34. Bendifallah S., Defert S., Chabbert-Buffet N., et al. Scoring to predict the possibility of upgrades to malignancy in atypical ductal hyperplasia diagnosed by an 11-gauge vacuum-assisted biopsy device: an external validation study. Eur J Cancer 2012, 48(1):30-36.
35. Forgeard C., Benchaib M., Guerin N., et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 2008, 196(3):339-345.
36. Nguyen C.V., Albarracin C.T., Whitman G.J., et al. Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol 2011, 18(3):752-761.
37. Sneige N., Lim S.C., Whitman G.J., et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 2003, 119(2):248-253.
38. Wagoner M.J., Laronga C., Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 2009, 131(1):112-121.
39. Nagi C.S., O'Donnell J.E., Tismenetsky M., et al. Lobular neoplasia on core needle biopsy does not require excision. Cancer 2008, 112(10):2152-2158.
40. Hartmann L.C., Sellers T.A., Frost M.H., et al. Benign breast disease and the risk of breast cancer. N Engl J Med 2005, 353(3):229-237.
41. Carter C.L., Corle D.K., Micozzi M.S., et al. A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 1988, 128(3):467-477.
42. London S.J., Connolly J.L., Schnitt S.J., et al. A prospective study of benign breast disease and the risk of breast cancer. JAMA 1992, 267(7):941-944.
43. Degnim A.C., Visscher D.W., Berman H.K., et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007, 25(19):2671-2677.
44. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90(18):1371-1388.
45. Vogel V.G., Costantino J.P., Wickerham D.L., et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 2006, 295(23):2727-2741.
46. Piubello Q., Parisi A., Eccher A., et al. Flat epithelial atypia on core needle biopsy: which is the right management?. Am J Surg Pathol 2009, 33(7):1078-1084.
47. Boulos F.I., Dupont W.D., Simpson J.F., et al. Histologic associations and long-term cancer risk in columnar cell lesions of the breast: a retrospective cohort and a nested case-control study. Cancer 2008, 113(9):2415-2421.
48. Valdes E.K., Feldman S.M., Boolbol S.K. Papillary lesions: a review of the literature. Ann Surg Oncol 2007, 14(3):1009-1013.
49. Chang J.M., Han W., Moon W.K., et al. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision. Ann Surg Oncol 2011, 18(9):2506-2514.
50. Sohn V., Keylock J., Arthurs Z., et al. Breast papillomas in the era of percutaneous needle biopsy. Ann Surg Oncol 2007, 14(10):2979-2984.
51. Lewis J.T., Hartmann L.C., Vierkant R.A., et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. Am J Surg Pathol 2006, 30:665-672.
52. Brenner R.J., Jackman R.J., Parker S.H., et al. Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?. AJR Am J Roentgenol 2002, 179(5):1179-1184.
53. Linda A., Zuiani C., Furlan A., et al. Radial scars without atypia diagnosed at imaging-guided needle biopsy: how often is associated malignancy found at subsequent surgical excision, and do mammography and sonography predict which lesions are malignant?. AJR Am J Roentgenol 2010, 194(4):1146-1151.
54. Berg J.C., Visscher D.W., Vierkant R.A., et al. Breast cancer risk in women with radial scars in benign breast biopsies. Breast Cancer Res Treat 2008, 108(2):167-174.
55. Diseases of the breast 1986, WB Saunders, Philadelphia. 3rd edition. C.D. Haagensen (Ed.).
56. Foote F.W., Stewart F.W. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941, 17(4):491-496.3.
57. Rosen P.P., Kosloff C., Lieberman P.H., et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 1978, 2(3):225-251.
58. Wheeler J.E., Enterline H.T., Roseman J.M., et al. Lobular carcinoma in situ of the breast. Long-term follow-up. Cancer 1974, 34(3):554-563.
59. Page D.L., Kidd T.E., Dupont W.D., et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22(12):1232-1239.
60. Kilbride K.E., Newman L.A. Chapter 25: lobular carcinoma in situ: clinical management. Diseases of the breast 2010, Lippincott Williams & Wilkins, Philadelphia. 4th edition. J.R. Harris, M.E. Lippman, M. Morrow (Eds.).
61. Bodian C.A., Perzin K.H., Lattes R. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer 1996, 78(5):1024-1034.
62. Li C.I., Anderson B.O., Daling J.R., et al. Changing incidence of lobular carcinoma in situ of the breast. Breast Cancer Res Treat 2002, 75(3):259-268.
63. Li C.I., Malone K.E., Saltzman B.S., et al. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001. Cancer 2006, 106(10):2104-2112.
64. Liberman L., Holland A.E., Marjan D., et al. Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 2007, 188(3):684-690.
65. Abner A.L., Connolly J.L., Recht A., et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 2000, 88(5):1072-1077.
66. Ciocca R.M., Li T., Freedman G.M., et al. Presence of lobular carcinoma in situ does not increase local recurrence in patients treated with breast-conserving therapy. Ann Surg Oncol 2008, 15(8):2263-2271.
67. Moran M., Haffty B.G. Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy. Int J Radiat Oncol Biol Phys 1998, 40(2):353-358.
68. Hussain M., Cunnick G.H. Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast-a review. Eur J Surg Oncol 2011, 37(4):279-289.